Price tag for a questionable Alzheimer’s treatment: $109,000 per patient, per year. Unclear yet: For how many years?

By SharpBrains | August 2, 2023

The real costs of the new Alzheimer’s drug, Leqem­bi — and why tax­pay­ers will foot much of the bill (CBS News): The first drug pur­port­ing to slow the advance of Alzheimer’s dis­ease is like­ly to cost the U.S. health care sys­tem bil­lions annu­al­ly even as it remains out of reach for many of the low­er-income seniors…

Read More

CMS: anti-amyloid drug Leqembi (lecanemab) doesn’t meet the “reasonable and necessary” standard required for wider Medicare coverage

By SharpBrains | February 28, 2023

CMS Sticks to Sharply Lim­it­ed Cov­er­age of New Alzheimer’s Drug, Leqem­bi (Man­aged Health­care Exec­u­tive): For now, CMS (Note: Cen­ters for Medicare & Med­ic­aid Ser­vices) is stick­ing to the cov­er­age deci­sion it made for Aduhelm (adu­canum­ab) and apply­ing it Leqem­bi (lecanemab). The deci­sion lim­its Medicare cov­er­age of the two Alzheimer disease’s drugs to Medicare ben­e­fi­cia­ries who…

Read More

Ballroom dancing can reduce aging-related brain atrophy in the hippocampus (and, more than treadmill walking!)

By The Conversation | January 11, 2023 |

Social ball­room danc­ing can improve cog­ni­tive func­tions and reduce brain atro­phy in old­er adults who are at increased risk for Alzheimer’s dis­ease and oth­er forms of demen­tia. That’s the key find­ing of my team’s recent­ly pub­lished study in the Jour­nal of Aging and Phys­i­cal Activ­i­ty. In our study, we enrolled 25 adults over 65 years…

Read More

Study finds sharp decrease (nearly one-third) in the prevalence of dementia among those 65+ in the United States

By SharpBrains | November 14, 2022

Demen­tia plum­mets by near­ly one-third among U.S. seniors, RAND says (UPI): The preva­lence of demen­tia in the Unit­ed States is declin­ing among peo­ple over age 65, falling dra­mat­i­cal­ly from 2000 to 2016, a RAND Corp. study says. Nation­wide, the age-adjust­ed preva­lence of demen­tia fell to 8.5% of peo­ple over age 65 in 2016, down by nearly…

Read More

Combined tDCS neurostimulation and cognitive training found to improve working memory among older adults–especially those with lower starting capacity

By SharpBrains | October 25, 2022

Giv­ing mem­o­ry a lift: Can games and brain stim­u­la­tion do it? (Med­ical­New­sTo­day): A person’s work­ing mem­o­ry may decline with age or if they have demen­tia, Parkinson’s dis­ease, or have had a stroke. When this occurs, the loss can affect their day-to-day qual­i­ty of life, turn­ing even sim­ple tasks into often-demor­­al­iz­ing challenges.

Read More